Mosquito
recruited to fight malaria
Modified insect would be released into wild
URL:
http://www.globeandmail.com/gam/Health/20000622/UVIVAN3.html
Date
accessed: 15 July 2000
Agence France-Presse
Thursday, June 22, 2000
Paris -- European scientists have created the world's first genetically
modified mosquito, in what they believe may be a step toward eliminating
malaria by introducing harmless versions of the insect into the wild.
The team introduced a piece of foreign DNA into mosquito eggs, which
then "jumped" into the chromosomes of the larva, according to
their
research, published in today's issue of the British weekly Nature.
The DNA comprises small circular molecules called plasmids that include
mobile sequences of genetic material.
In this case, the plasmids controlled a fluorescent protein, which makes
the mosquito glow an eerie green when it is exposed to ultraviolet light.
The glow has a laboratory use -- to show researchers at a glance
whether the modified gene has been
conferred to subsequent generations
of the insect.
But, the scientists write, other genes could also be inserted, with a
potential boon for humanity.
A strain of mosquitoes could be bred that no longer harbours or
transmits the malaria parasite, which is passed on to humans when the
insect drinks their blood.
Work could draw on a wealth of experience in figuring out the genetic
makeup of a cousin species, the fruit fly drosophila.
"The successful transformation of a mosquito vector of human malaria
is
a notable advance in our ability to combat this devastating
disease," adds
Craig Coates, of Texas A and M University, in an adjoining commentary
in Nature.
He cautions, however, that the environmental impact of releasing the
modified flies would have to be carefully assessed.
The research was conducted by scientists from London's Imperial
College, the European Molecular Biology Laboratory in Heidelberg,
Germany, and the Institute of Molecular Biology and Biotechnology in
Crete, Greece.
Hundreds of millions of people living in tropical and subtropical
climates
are affected by malaria-carrying mosquitoes.
Ninety per cent of cases, accounting for an estimated one million deaths
a year, are in sub-Saharan Africa, where the main culprit is a strain of
mosquito called anopheles gambiae.
There is no viable vaccine against the malaria parasite, which is also
becoming resistant to the most commonly used drugs.
In addition, control of mosquito populations is being hampered by
resistance to insecticides and environmental worries about the long-term
impact from the most effective chemicals, such as DDT.
Category: 29. GMOs